C361 XAP1-Task 1 Evidenced Based Practice Running head: EVIDENCED BASED PRACTICE C361 XAP1-Task 1 Evidenced Based Practice C361 XAP1-Task 1 Quantitative: Article Areas A1 Quantitative Article: Dal Molin, A., Cleri
...
C361 XAP1-Task 1 Evidenced Based Practice Running head: EVIDENCED BASED PRACTICE C361 XAP1-Task 1 Evidenced Based Practice C361 XAP1-Task 1 Quantitative: Article Areas A1 Quantitative Article: Dal Molin, A., Clerico, M., Baccini, M., Guerretta, L., Sartorello, B., & Rasero, L. (2015). Normal saline versus heparin solution to lock totally implanted venous access devices: Results from a multicenter randomized trial. European Journal Of Oncology Nursing, 19638-643. doi:10.1016/j.ejon.2015.04.001 Background or Introduction The authors purpose statement was “to determine the non-inferiority of normal saline flushing compared to heparin flushing in maintaining the patency of totally implanted venous access devices (TIVADs) (Dal Molin, A., Clerico, M., Baccini, M., Guerretta, L., Sartorello, B., & Rasero, L., 2015). The purpose statement does make sense and it is easy to comprehend the healthcare problem. There is an abstract at the beginning of the article that is clearly structured. It also provided enough information on the subject for me to become interested in the topic. The article also includes an introduction of the topic, the introduction is clearly bolded at the beginning of the article. However the introduction does not seem to be as organized as other articles that I have seen in the past. Review of the Literature There was not a section labeled literature review for this article. Furthermore, there was not any discussion of the past research discussed in the. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. . . . . .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. . .. .. . . . . . . . . . . . . . . . . . .. . . . .
[Show More]
